Page last updated: 2024-11-07

2-hydroxyethylvaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-hydroxyethylvaline: RN given refers to (DL)-isomer; RN for cpd without isomeric designation not available 11/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107912
SCHEMBL ID3294007
MeSH IDM0160741

Synonyms (11)

Synonym
2-hydroxyethylvaline
n-2-(hydroxyethyl)-l-valine
FT-0669626
21768-51-4
n-(2-hydroxyethyl)valine
dl-valine, n-(2-hydroxyethyl)-
SCHEMBL3294007
2-(2-hydroxyethylamino)-3-methylbutyric acid, 97% (cp)
n-2-(hydroxyethyl)-l-valine-d4(technical grade)
FT-0669627
n-(2-hydroxyethyl)-dl-valine

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" By analyzing published data on ethylene oxide in man its half-life was estimated to be 42 min."( Pharmacokinetics of ethylene in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene.
Denk, B; Ehrenberg, L; Filser, JG; Kessler, W; Törnqvist, M, 1992
)
0.28

Dosage Studied

ExcerptRelevanceReference
" A novel method using gas chromatography-mass spectrometry (GC-MS) has been used to monitor the presence of this adduct in smokers and control subjects, and dose-response relationships were investigated between HOEtVal in haemoglobin, number of cigarettes smoked per day and plasma cotinine levels."( 2-Hydroxyethylation of haemoglobin in man.
Bailey, E; Brooks, AG; Farmer, PB; Passingham, BJ; Yates, DW, 1988
)
0.27
" The dose-response curves for 7-HEG in rat tissues were linear between 10 and 100 ppm ETO and increased in slope above 100 ppm."( Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide.
Fennell, TR; MacNeela, JP; Swenberg, JA; Upton, PB; Walker, VE, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (14.29)18.7374
1990's17 (48.57)18.2507
2000's7 (20.00)29.6817
2010's4 (11.43)24.3611
2020's2 (5.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.10 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.56%)5.53%
Reviews4 (10.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (87.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]